ArticleTherapeutic advances in gastroenterology2025
Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH study.
Linda Ryen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.